Tumor-targeting peptides from combinatorial libraries

Ruiwu Liu1, Xiaocen Li1, Wenwu Xiao1

  • 1Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA 95817, USA; University of California Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA.

Insights

Discovering tumor-targeting peptides is crucial for early cancer detection and effective treatments. Combinatorial library technologies like phage display and one-bead one-compound (OBOC) are key methods for identifying these vital peptide ligands.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Cancer remains a leading global cause of mortality, with significant challenges in early detection and treatment side effects.
  • Targeted therapies and molecular imaging necessitate high-affinity, tumor-specific agents for delivering therapeutics and imaging probes.
  • Combinatorial libraries offer powerful strategies for identifying peptides that target tumors.

Purpose of the Study:

  • To provide an overview of combinatorial library technologies used for discovering tumor-targeting peptides.
  • To discuss examples of tumor-targeting peptides identified using these methods.
  • To summarize published peptide ligands, their applications, and corresponding binding receptors.

Main Methods:

  • Phage-display peptide libraries
  • One-bead one-compound (OBOC) peptide libraries
  • Review of existing literature on combinatorial library technologies for peptide discovery

Main Results:

  • Various combinatorial library technologies have been successfully employed to discover tumor-targeting peptides.
  • Specific examples of identified peptide ligands and their targeted receptors are presented.
  • The review categorizes and summarizes peptide ligands based on discovery method and binding targets.

Conclusions:

  • Combinatorial libraries are essential tools for identifying effective tumor-targeting peptides.
  • These peptides hold significant potential for advancing cancer diagnostics and therapeutics.
  • Further research into peptide ligands and their applications can improve cancer patient outcomes.

Related Concept Videos